Main Session
Sep
30
QP 47 - Research Highlights from Around the Globe
3726 - WGS-Based Personalized ctDNA Assay for Molecular Residual Disease (MRD) Detection in Locally Advanced Cervical Cancer Treated with Definitive Chemoradiotherapy: Interim Results from a Prospective Multicenter Study (MONSTAR-SCREEN-3)
Presenter(s)
Masaki Nakamura, MD - National Cancer Center Hospital East, Kashiwa, Chiba